Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

The top domestic tobacco company still faces severe secular headwinds.

Why I'll Never Own Altria Stock

Franklin Resources

Black Hills

Cincinnati Financial

Community Trust Bancorp

Federal Realty Investment Trust

Johnson & Johnson

National Fuel Gas

Northwest Natural Gas

Sysco

Telephone and Data Systems

United Bankshares

Universal Corp

Walgreens

Drip Investing lists over 800 stocks that have annually increased dividends for five years or more. The 65 stocks, boosting dividends annually 40+ years, were parsed from 136 Champions posted 10/31. These 65 select dividend stocks ranged 0.78% to 9.53% in annual yield and ranged -5.22% to 87.65% in annual price target upsides per brokers sampled 11/2/20.

65 40-Year Plus Annual Dividend Boosters In November

When Altria released their results for the third quarter of 2020, they once again disappointed shareholders with yet another Juul impairment. Whilst this has destroyed billions of dollars of shareholder value, at least if nothing else, it has not endangered their cherished dividends.

Altria: More Juul Disappointment Overshadows Strong Dividend Potential

The price target of the Altria Group Inc (NYSE: MO) stock has been lowered from $57 to $47 by Piper Sandler. These are the details.

MO Stock: $47 Price Target By Piper Sandler

A recent article on Seeking Alpha indicated that Altria would have hurt shareholders, even with dividends, over the past several years. Despite this, the company has actually had a stellar 2020, which is expected to continue going forward.

Altria - Don't Dwell In The Past

Aphria

Curaleaf Holdings, Inc.

GW Pharmaceuticals

Innovative Industrial Properties

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Scotts Miracle-Gro

Constellation Brands

Investors keep waiting for marijuana stocks to come to life. In 2020, the Prime Alternative Harvest Index, which covers many of the major global cannabis companies, hasn't been good.

10 Best Marijuana Stocks to Buy for 2021

Altria is best of breed in the world of smoke and smokeless products. This is the top of all Dividend Kings, with a 9.53% yield and 54 consecutive dividend increases in the past 50 years.

Altria: Costly Lessons You Must Learn

AT&T

AT&T 5.35 % Notes 2017-01.11.66 Global

Exxon Mobil

I have written about these dividend aristocrats and kings quite often. I cannot recall if I have ever seen three wonderful companies - and dividend aristocrats - viewed so negatively by so many investors without good reason.

Retirement Strategy: A Contrarian, Speculator, And Dividend Growth Investor, All At Once

AmerisourceBergen

Arrow Financial

Chubb

Enbridge

Enterprise Products Partners

Essex Property Trust

Kimberly-Clark

Northrop Grumman

Philip Morris

Sanofi

UMB Financial

The pandemic is out of control all over the world, with daily records in new cases and a mounting death toll. Europe is beginning to lock down again and IHME expects up to 20 US states to follow suit starting in late November.

15 High-Yield/Low Volatility Blue Chips For The Ultimate Crash-Proof Retirement Portfolio

Altria is substantially undervalued right now and can only be described as a steal. With Altria you get a stable business with a healthy growth rate, a product in demand fueled by pandemic tailwinds and an almost double-digit yield supported by a healthy payout ratio.

Altria: Pandemic Tailwinds And Investments Going Up In Smoke

Canopy Growth

Cronos Group

Charlotte's Web Holdings, Inc.

Decriminalizing pot won't solve all these problems.

5 Ways the Federal Government Is Harming the Cannabis Industry

Altria Group, Inc. (MO) CEO Billy Gifford on Q3 2020 Results - Earnings Call Transcript

Altria's (MO) third-quarter 2020 results reflect strong pricing in smokeable and oral tobacco product segments. Management lifts the lower end of its previously guided earnings view.

Altria's (MO) Q3 Earnings Surpass Estimates on Solid Pricing

U.S. cigarette industry volume declines continued to stabilise in Q3, with the e-vapor threat receding and COVID-19 seemingly a positive. On an adjusted basis, Altria's cigarette volumes were down only 1% year-on-year for Q3, and only 2% year-to-date.

Altria: With Strong Q3 Results, This Stock Could Double By 2023 Year-End

It's a long way down for an e-cig maker that held such promise.

Altria's Juul Investment Devalued to Just $1.6 Billion

Altria (MO) delivered earnings and revenue surprises of 3.48% and 2.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Tops Q3 Earnings and Revenue Estimates

  Shares of Altria Group (NYSE:MO) rose 0.6% in pre-market trading after the company reported Q3 results.

Altria Group: Q3 Earnings Insights

Altria Group Inc said on Friday it took a $2.6 billion charge on its investment in Juul Labs Inc in the third quarter, mainly due to lower revenue projection from the e-cigarette maker.

Marlboro maker Altria takes $2.6 billion third-quarter hit on Juul investment

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE:MO) announces that Dr. Ellen R. Strahlman will join its Board of Directors on November 2, 2020. Dr. Strahlman served as Executive Vice President, Research & Development and Chief Medical Officer of Becton, Dickinson and Company, a leading global medical technology company, from April 2013 until her retirement in January 2018. Before joining Becton Dickinson and Company, she served as a Senior Advisor to the CEO at GlaxoSmithK

Dr. Ellen R. Strahlman Elected to Altria's Board of Directors

RICHMOND, Va.--(BUSINESS WIRE)-- #2020guidance--Altria Group, Inc. (Altria) (NYSE: MO) today announces its 2020 third-quarter and nine-months business results and narrows its 2020 adjusted diluted earnings per share (EPS) guidance. “Altria continued to demonstrate its resilience during the third quarter while navigating the challenges presented by the COVID-19 pandemic,” said Billy Gifford, Altria's Chief Executive Officer. “In the third quarter, our tobacco businesses delivered strong financial performance on

Altria Reports 2020 Third-Quarter and Nine-Months Results; Tobacco Businesses Demonstrate Resilience; Narrows 2020 Full-Year Earnings Guidance

Shares of Altria Group Inc. rose 0.8% in premarket trading Friday, after the Marlboro cigarettes parent reported a narrower net loss, while the adjusted profit and revenue beat expectations. The net loss was $952 million, or 51 cents a share, after a loss of $2.60 billion, or $1.39 a share, in the year-ago period.

Altria records $2.6 billion charge on JUUL investment, but adjusted profit tops expectations

Juul's valuation took a big hit Thursday. Since tobacco company Altria Group acquired a large stake in Juul Labs, the vape manufacturer has struggled with regulatory issues and has seen its valuation fall several times.

Juul Group Cuts Valuation To $10B, Sinking Altria's Investment Further

Kraft Heinz

Bunge Global SA

Chevron

General Mills

Kinder Morgan

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

In this article we present the list of 10 best high dividend stocks to buy now. Click to skip ahead and see the top 5 high dividend stocks to buy .

10 Best High Dividend Stocks To Buy Now

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at delivering attractive risk-adjusted returns rather than following the ups and downs of equity markets hoping that they will outperform the broader market. Our research shows that certain hedge funds do have great stock picking skills (and we can identify these hedge funds in advance pretty accurately), so let's take a glance at the smart money sentiment towards Altria Group Inc (NYSE:MO).

Were Hedge Funds Right About Getting Out Of Altria Group Inc (MO)?

Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Altria (MO) Might Surprise This Earnings Season

News for Altria Stock (MO)